Reviva Pharmaceuticals exotic insider transaction detected
RVPH Stock | USD 1.40 0.90 39.13% |
Under 55% of Reviva Pharmaceuticals' traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Reviva Pharmaceuticals Holdings suggests that some traders are interested. Reviva Pharmaceuticals' investing sentiment shows overall attitude of investors towards Reviva Pharmaceuticals Holdings.
Reviva |
Filed transaction by Reviva Pharmaceuticals Ho executive. Unconventional Insider trading
Read at macroaxis.com
Reviva Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Reviva Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Reviva Pharmaceuticals Fundamental Analysis
We analyze Reviva Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reviva Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reviva Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Reviva Pharmaceuticals is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Reviva Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Reviva Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Reviva Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Reviva Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Reviva Pharmaceuticals Related Equities
ZVSA | ZyVersa Therapeutics | 10.00 | ||||
CUE | Cue Biopharma | 3.92 | ||||
INAB | In8bio | 3.57 | ||||
CABA | Cabaletta Bio | 1.48 | ||||
PLX | Protalix Biotherapeutics | 0.57 | ||||
UNCY | Unicycive Therapeutics | 1.41 | ||||
FBIO | Fortress Biotech | 2.75 | ||||
ACAD | ACADIA Pharmaceuticals | 2.87 | ||||
LTRN | Lantern Pharma | 3.65 | ||||
SLS | Sellas Life | 4.35 | ||||
EYPT | Eyepoint Pharmaceuticals | 7.23 | ||||
ATHA | Athira Pharma | 8.47 |
Complementary Tools for Reviva Stock analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |